This slide deck summarises the latest evidence supporting an association between hypertriglyceridaemia and atherosclerotic cardiovascular disease even when LDL-cholesterol is well controlled, and considers the potential of triglycerides and triglyceride-rich lipoprotein remnants as targets for future therapies to reduce residual cardiovascular risk and acute pancreatitis.
